Structural organization of the thrombospondin molecule.
Lawler, J, and R O Hynes. 1987. “Structural Organization of the Thrombospondin Molecule.”. Seminars in Thrombosis and Hemostasis 13 (3): 245-54.
Search
Search results
5006 results found
Thrombospondin in essential thrombocythemia.
Lawler, J, A M Cohen, F C Chao, and D J Moriarty. 1986. “Thrombospondin in Essential Thrombocythemia.”. Blood 67 (2): 555-8.
Hemin-mediated dissociation of erythrocyte membrane skeletal proteins.
Liu, S C, S Zhai, J Lawler, and J Palek. 1985. “Hemin-Mediated Dissociation of Erythrocyte Membrane Skeletal Proteins.”. The Journal of Biological Chemistry 260 (22): 12234-9.
Molecular defect of spectrin in hereditary pyropoikilocytosis. Alterations in the trypsin-resistant domain involved in spectrin self-association.
Lawler, J, S C Liu, J Palek, and J Prchal. 1982. “Molecular Defect of Spectrin in Hereditary Pyropoikilocytosis. Alterations in the Trypsin-Resistant Domain Involved in Spectrin Self-Association.”. The Journal of Clinical Investigation 70 (5): 1019-30.
Prediction of the secondary structure of platelet factor 4 and beta-thromboglobulin from their amino acid sequences.
Lawler, J W. 1981. “Prediction of the Secondary Structure of Platelet Factor 4 and Beta-Thromboglobulin from Their Amino Acid Sequences.”. Thrombosis Research 21 (1-2): 121-7.
The effect of ultraviolet light on platelets: platelet activation and inhibition of thrombin-mediated functions.
Lawler, J W, F C Chao, and P H Fang. 1979. “The Effect of Ultraviolet Light on Platelets: Platelet Activation and Inhibition of Thrombin-Mediated Functions.”. Thrombosis Research 14 (2-3): 489-94.
Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.
Lawler, J W, H S Slayter, and J E Coligan. 1978. “Isolation and Characterization of a High Molecular Weight Glycoprotein from Human Blood Platelets.”. The Journal of Biological Chemistry 253 (23): 8609-16.
Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.
Duquette, Mark, Peter M Sadow, Jack Lawler, and Carmelo Nucera. 2020. “Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.”. Frontiers in Endocrinology 11: 596223.
Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.
Russell, Samantha, Mark Duquette, Joyce Liu, Ronny Drapkin, Jack Lawler, and Jim Petrik. 2015. “Combined Therapy With Thrombospondin-1 Type I Repeats (3TSR) and Chemotherapy Induces Regression and Significantly Improves Survival in a Preclinical Model of Advanced Stage Epithelial Ovarian Cancer.”. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 29 (2): 576-88.
Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.
Ibanez, Laura, Umber Dube, Benjamin Saef, John Budde, Kathleen Black, Alexandra Medvedeva, Jorge L Del-Aguila, et al. 2017. “Parkinson Disease Polygenic Risk Score Is Associated With Parkinson Disease Status and Age at Onset But Not With Alpha-Synuclein Cerebrospinal Fluid Levels.”. BMC Neurology 17 (1): 198.